ChromoTek GmbH offers nanobody based real time assays to visualize and measure the action of candidate drugs or other substances of interest on important regulatory processes in living cells. Presently, four Chromobody ® plasmids are available for analyzing the cell cycle, apoptosis, DNA methylation and cytoskeleton dynamics.
reMYND NV announced today that Bernd Bohrmann (Neuroscience, Roche) is presenting preclinical efficacy data at the leading AD/PD conference held March 6th-10th in Florence, on a novel combination therapy tested in an Alzheimer mouse model in collaboration with reMYND's Contract Research Organization (CRO).
This year, the EU Regulation on cosmetic products (Regulation 1223/2009) introduces new requirements related to safety of the cosmetic products as well as new registration procedures.
CROMSOURCE, an international full service contract research organization (CRO), today announced a unique alternative to the routine delays and budget escalations which characterise the delivery of clinical trials. CROMSOURCE now offers clients the industry's only End-to-End Guarantee. Within this pledge CROMSOURCE assures clients that their projects will be delivered according to the contracted timelines and to the price written on the contract.
Tunnels are equipped with Intense Pulsed UV flash lamps, have UV transparent conveyer and capable to sterilize the entire product surfaces with the reduction from bacteria and spores for up to 6 log (1: million).
Worldwide Clinical Trials Inc, today acknowledged receipt of strong ratings and recommendations from one of the industry’s leading independent market research firms, Industry Standard Research (ISR). In ISR’s recently published, ‘2012 CRO Quality Benchmarking Report’, CROs (Clinical Research Organisations) were quantitatively assessed for delivery strengths and weaknesses. Sponsors' selection drivers, outsourcing volume, and provider preferences were also measured.
Merge Healthcare Incorporated, a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that Worldwide Clinical Trials, Inc. has selected Merge's eClinical OS™ solution to accelerate study startup, streamline electronic data capture (EDC), and maximize operational efficiency across its Phase I-IV studies.
GVK Biosciences Pvt. Ltd., a leading provider of databases and services to the Life Sciences industry, has selected GGA as its distributor for its Informatics Database products and services in Taiwan.
Refrigerated incubators create a constant microclimate for the development and growth processes of microorganisms and cell cultures. They are part of every laboratory where cell biology, microbiology or molecular biology methods are used in biology, medicine, pharmaceutical research or the food industry.
SHL announced plans this week to expand production facilities in Taiwan. A leader in the field of drug delivery devices such as auto injectors and pen injectors, SHL has continued to invest heavily in facilities, advanced machinery and R&D. With the rapid growth of the biologic injectable market, device suppliers are under pressure to broaden the range of services that they can provide. SHL has responded by making significant capital investments such as the 40 Million USD that will be spent this year alone.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.